Cargando…
Immortal time bias in retrospective analysis: comment on ‘Efficacy and safety of long-term treatment with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma'
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4349258/ https://www.ncbi.nlm.nih.gov/pubmed/25723854 http://dx.doi.org/10.1038/bcj.2015.4 |
| _version_ | 1782360018933252096 |
|---|---|
| author | Hsieh, P-Y Liu, C-J Teng, C-J |
| author_facet | Hsieh, P-Y Liu, C-J Teng, C-J |
| author_sort | Hsieh, P-Y |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4349258 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-43492582015-03-10 Immortal time bias in retrospective analysis: comment on ‘Efficacy and safety of long-term treatment with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma' Hsieh, P-Y Liu, C-J Teng, C-J Blood Cancer J Letter to the Editor Nature Publishing Group 2015-02 2015-02-27 /pmc/articles/PMC4349258/ /pubmed/25723854 http://dx.doi.org/10.1038/bcj.2015.4 Text en Copyright © 2015 Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
| spellingShingle | Letter to the Editor Hsieh, P-Y Liu, C-J Teng, C-J Immortal time bias in retrospective analysis: comment on ‘Efficacy and safety of long-term treatment with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma' |
| title | Immortal time bias in retrospective analysis: comment on ‘Efficacy and safety of long-term treatment with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma' |
| title_full | Immortal time bias in retrospective analysis: comment on ‘Efficacy and safety of long-term treatment with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma' |
| title_fullStr | Immortal time bias in retrospective analysis: comment on ‘Efficacy and safety of long-term treatment with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma' |
| title_full_unstemmed | Immortal time bias in retrospective analysis: comment on ‘Efficacy and safety of long-term treatment with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma' |
| title_short | Immortal time bias in retrospective analysis: comment on ‘Efficacy and safety of long-term treatment with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma' |
| title_sort | immortal time bias in retrospective analysis: comment on ‘efficacy and safety of long-term treatment with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma' |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4349258/ https://www.ncbi.nlm.nih.gov/pubmed/25723854 http://dx.doi.org/10.1038/bcj.2015.4 |
| work_keys_str_mv | AT hsiehpy immortaltimebiasinretrospectiveanalysiscommentonefficacyandsafetyoflongtermtreatmentwithlenalidomideanddexamethasoneinpatientswithrelapsedrefractorymultiplemyeloma AT liucj immortaltimebiasinretrospectiveanalysiscommentonefficacyandsafetyoflongtermtreatmentwithlenalidomideanddexamethasoneinpatientswithrelapsedrefractorymultiplemyeloma AT tengcj immortaltimebiasinretrospectiveanalysiscommentonefficacyandsafetyoflongtermtreatmentwithlenalidomideanddexamethasoneinpatientswithrelapsedrefractorymultiplemyeloma |